Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer

被引:1
|
作者
Chen, Li [1 ]
Zhang, Gumuyang [1 ]
Xu, Lili [1 ]
Zhang, Xiaoxiao [1 ]
Zhang, Jiahui [1 ]
Bai, Xin [1 ]
Jin, Ru [1 ]
Mao, Li [2 ]
Xiao, Xin [2 ]
Li, Xiuli [2 ]
Xie, Yi [3 ]
Jin, Zhengyu [1 ,4 ]
Sun, Hao [1 ,4 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Radiol, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China
[2] Deepwise Healthcare, Deepwise AI Lab, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Urol, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China
[4] Natl Ctr Qual Control Radiol, Beijing, Peoples R China
关键词
Urinary bladder neoplasms; Tomography; X-Ray computed; Risk assessment; Algorithms; Retrospective studies; DIAGNOSIS;
D O I
10.1007/s00261-022-03730-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To investigate whether preoperative CT features can be used to predict risk stratification of non-muscle invasive bladder cancer (NMIBC).Methods The 168 patients with pathologically confirmed NMIBC who underwent preoperative CT urography were retrospectively analyzed and were divided into training (n = 117) and testing (n = 51) sets. According to the European Association of Urology Guidelines, patients were classified into low-risk (n = 50), medium-risk (n = 23), and high-risk (n = 95) groups. A random over-sample was performed to handle the offset caused by the unbalanced groups. We measured some CT features that may help stratify which for modeling were determined using an F-test-based feature selection with a tenfold cross-validation procedure, and the Gaussian Naive Bayes model was trained on the entire training set. In the testing set, the performance of the model was evaluated.Results The selected CT features were the maximum and the minimum diameter of the largest tumor, whether the largest tumor is located at the trigone, and tumor number. In the testing set, the model reached a macro- and micro- AUC of 0.783 and 0.745 with an accuracy of 0.529. As for the one-vs-rest problem, the model was most effective in identifying low-risk individuals, with an AUC, accuracy, sensitivity, and specificity of 0.870, 0.647, 1.000, and 0.438, respectively; the medium-risk group reached 0.814, 0.882, 0.250, and 0.936, respectively; the identification of the high-risk group was harder, going 0.665, 0.529, 0.250, and 0.870, respectively.Conclusion It is feasible to predict the risk stratification of NMIBC using preoperative CT features.
引用
收藏
页码:659 / 668
页数:10
相关论文
共 50 条
  • [1] Preoperative CT features to predict risk stratification of non-muscle invasive bladder cancer
    Li Chen
    Gumuyang Zhang
    Lili Xu
    Xiaoxiao Zhang
    Jiahui Zhang
    Xin Bai
    Ru Jin
    Li Mao
    Xin Xiao
    Xiuli Li
    Yi Xie
    Zhengyu Jin
    Hao Sun
    [J]. Abdominal Radiology, 2023, 48 : 659 - 668
  • [2] Non-muscle invasive bladder cancer risk stratification
    Isharwal, Sumit
    Konety, Badrinath
    [J]. INDIAN JOURNAL OF UROLOGY, 2015, 31 (04) : 289 - 296
  • [3] Integrating genomic alterations and histopathological features for enhanced risk stratification in non-muscle invasive bladder cancer
    Lillesand, Melinda
    Kvikstad, Vebjorn
    Gudlaugsson, Einar
    Skaland, Ivar
    Johannessen, Aida Slewa
    Tesfahun, Almaz Nigatu
    Sperstad, Sigmund Vegard
    Janssen, Emiel A. M.
    Austdal, Marie
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [4] Immunotherapy of High Risk Non-Muscle Invasive Bladder Cancer
    Ahdoot, Michael
    Theodorescu, Dan
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (11) : 1345 - 1352
  • [5] Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
    Ieda, Takeshi
    Muto, Satoru
    Shimizu, Fumitaka
    Taguri, Masataka
    Yanada, Shigeto
    Kitamura, Kousuke
    Terai, Kazutaka
    Saito, Keisuke
    Ogishima, Tatsuya
    Nagata, Masayoshi
    Ide, Hisamitsu
    Okegawa, Takatsugu
    Wakumoto, Yoshiaki
    Sakamoto, Yoshiro
    Tsujimura, Akira
    Yamaguchi, Raizo
    Nutahara, Kikuo
    Horie, Shigeo
    [J]. EBIOMEDICINE, 2016, 12 : 98 - 104
  • [6] STRATIFICATION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: IMPLICATIONS FOR ADJUVANT THERAPIES
    Soria, Francesco
    D'andrea, David
    Gust, Kilian
    Gontero, Paolo
    Shariat, Shahrokh
    [J]. ANTICANCER RESEARCH, 2019, 39 (03) : 1593 - 1594
  • [7] Prognostic value of preoperative inflammation markers in non-muscle invasive bladder cancer
    Yildiz, Huseyin Alperen
    Deger, Muslim Dogan
    Aslan, Guven
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [8] Non-Muscle Invasive Bladder Cancer Preface
    Chang, Sam S.
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2013, 40 (02) : XIII - XIII
  • [9] Immunotherapy for non-muscle invasive bladder cancer
    Cathomas, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [10] NON-MUSCLE INVASIVE BLADDER CANCER IN 2012
    Esuvaranathan, Kesavan
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 123 - 123